Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$5.51
-3.5%
$5.11
$3.55
$11.16
$446.90M1.132.82 million shs2.41 million shs
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$1.77
-1.7%
$1.84
$1.14
$80.00
$296K-0.47892,399 shs705,118 shs
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.16
+5.5%
$1.04
$0.77
$3.12
$95.83M0.98362,153 shs199,550 shs
Optec International, Inc. stock logo
OPTI
Optec International
$0.00
-18.2%
$0.00
$0.00
$0.00
$21KN/A977,461 shs154,629 shs
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
-3.50%-5.81%+8.68%-7.24%-24.83%
Bon Natural Life Limited stock logo
BON
Bon Natural Life
-1.67%+16.45%+23.34%-92.43%-97.58%
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
+5.45%+3.57%+7.41%-1.69%-50.64%
Optec International, Inc. stock logo
OPTI
Optec International
-18.18%-10.00%-28.00%-40.00%+5.88%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altimmune, Inc. stock logo
ALT
Altimmune
2.4589 of 5 stars
3.51.00.00.02.73.30.6
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/AN/AN/AN/AN/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
2.2363 of 5 stars
3.73.00.00.02.70.00.6
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
3.00
Buy$20.20266.61% Upside
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.00
N/AN/AN/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
3.40
Buy$8.67647.13% Upside
Optec International, Inc. stock logo
OPTI
Optec International
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BON, CRDL, OPTI, and ALT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/16/2025
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
4/7/2025
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
4/3/2025
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/18/2025
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/14/2025
Altimmune, Inc. stock logo
ALT
Altimmune
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
3/3/2025
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
2/28/2025
Altimmune, Inc. stock logo
ALT
Altimmune
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$20K22,344.98N/AN/A$2.75 per share2.00
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$23.84M0.01$2.27 per share0.78$37.78 per share0.05
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/A$0.32 per shareN/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$88.45M-$1.26N/AN/AN/A-199,076.92%-55.81%-50.60%8/6/2025 (Estimated)
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$400KN/A0.00N/AN/AN/AN/AN/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$20.84M-$0.34N/AN/AN/AN/A-194.40%-129.07%7/14/2025 (Estimated)
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/A0.00N/AN/AN/AN/AN/A

Latest BON, CRDL, OPTI, and ALT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.35-$0.26+$0.09-$0.26$0.00 million$0.01 million
3/31/2025Q4 2024
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$0.08-$0.07+$0.01-$0.07N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/AN/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/AN/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
N/A
16.87
16.87
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.02
2.42
2.32
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
0.01
2.49
2.49
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
78.05%
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.57%
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
12.49%
Optec International, Inc. stock logo
OPTI
Optec International
N/A

Insider Ownership

CompanyInsider Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
4.10%
Bon Natural Life Limited stock logo
BON
Bon Natural Life
26.48%
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
5.25%
Optec International, Inc. stock logo
OPTI
Optec International
50.34%
CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
5081.11 million68.21 millionOptionable
Bon Natural Life Limited stock logo
BON
Bon Natural Life
100167,000863,000Not Optionable
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
2082.61 million78.27 millionNot Optionable
Optec International, Inc. stock logo
OPTI
Optec International
111.65 millionN/ANot Optionable

Recent News About These Companies

Optec International Inc.
Optec Technology Ltd.
New Optec CEO Updates Shareholders
New Optec CEO Updates Shareholders
SITC International Expands Fleet with New Vessel Orders
OGP exhibiting exciting lineup of metrology systems at IMTS 2024

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Altimmune stock logo

Altimmune NASDAQ:ALT

$5.51 -0.20 (-3.50%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$5.52 +0.01 (+0.18%)
As of 05/27/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Bon Natural Life stock logo

Bon Natural Life NYSE:BON

$1.77 -0.03 (-1.67%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$1.74 -0.02 (-1.41%)
As of 05/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.

Cardiol Therapeutics stock logo

Cardiol Therapeutics NASDAQ:CRDL

$1.16 +0.06 (+5.45%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$1.16 0.00 (-0.34%)
As of 05/27/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Optec International stock logo

Optec International OTCMKTS:OPTI

$0.0018 0.00 (-18.18%)
As of 05/27/2025 03:46 PM Eastern

Optec International, Inc. engages in selling and marketing optimized fuel maximizer units in North America and internationally. It markets optimized fuel maximizer for passenger vehicles, intermediate/medium duty trucks, off-road equipment, generator systems, heavy duty diesel on-road vehicles, and transportation refrigeration units. The company was formerly known as Green Meadow Products, Inc. and changed its name to Optec International, Inc. in August 2017. Optec International, Inc. was founded in 2012 and is based in Carlsbad, California.